Overweight is associated with better one-year survival in elderly patients after cardiac surgery: a retrospective analysis of the MIMIC-III database.

BACKGROUND: The relationship of body mass index (BMI) to short- and long-term outcomes after cardiac surgery remains controversial, and the dose-response relationship between BMI and mortality in patients receiving cardiac surgery is unclear. Furthermore, the influence of age, concomitant disease, and types of surgery on the prognostic role of BMI has yet to be determined.
METHODS: A retrospective cohort study with 6,473 adult patients receiving cardiac surgery was conducted using the Multiparameter Intelligent Monitoring in Intensive Care (MIMIC-III) database. Multivariate Cox proportional hazard analysis and multivariate logistic regression analysis were used to assess the association of BMI with 1-year and in-hospital mortality. Restricted cubic regression splines were used to evaluate the effect of BMI as a continuous variable and to determine appropriate cut points. Subgroup analyses were performed based on age, hypertension and types of surgery.
RESULTS: The baseline characteristics of patients differed between BMI categories. On multivariable analysis, overweight patients (BMI 25-30 kg/m2) had a lower 1-year mortality [hazard ratio (HR) =0.660, 95% confidence interval (CI): 0.516-0.843, P=0.001] when compared with normal weight patients (BMI 18.5-25 kg/m2). For patients with BMI <30 kg/m2, each 1 kg/m2 BMI increase was independently associated with a significant decrease in the 1-year mortality risk (HR =0.936, 95% CI: 0.899-0.975, P=0.002), while in patients with BMI ≥30 kg/m2, an increase in BMI did not increase the 1-year mortality risk (HR =1.032, 95% CI: 0.998-1.067, P=0.064). Subgroup analyses suggested the protective effect of overweight on post-cardiac surgery survival was confined to patients with advanced age (>60 years), hypertension and those undergoing isolated coronary artery bypass grafting (CABG).
CONCLUSIONS: Overweight was associated with better 1-year survival in patients after cardiac surgery when compared to normal weight. The protective effect of overweight on post-cardiac surgery survival was confined to elderly patients (>60 years). 2021 Journal of Thoracic Disease. All rights reserved.

Introduction

The prevalence of obesity [body mass index (BMI) ≥30 kg/m2] and overweight (BMI 25–30 kg/m2) has risen dramatically during the past four decades (1). Obesity adversely affects cardiovascular hemodynamics, structure and function, and increases the risk of most cardiovascular disease (2). Meanwhile, a so called “obesity paradox” has been noted in various studies, suggesting that while obesity has been associated with higher all-cause mortality, overweight has been associated with lower all-cause mortality (3). It has also been shown that obesity could play a protective role in acute coronary syndromes (4) and heart failure (5).

The relationship between body mass index (BMI) and the prognosis of cardiovascular surgery has been reported in several studies. A large nationwide cohort study reported obesity to be associated with lower in-hospital mortality after cardiac surgery (6), and a recent meta-analysis suggested a U-shaped relationship between BMI and all-cause mortality following cardiac surgery (7). However, some recent cohort studies have failed to find a relationship between BMI and early/long-term outcome after cardiac surgery (8,9). The protective effect of obesity might be explained by potential mechanisms such as adipokines secretion, reducing oxidative stress and inflammation, and lowering levels of B-type natriuretic peptide (10). While some suggested that the obese paradox might rather be a product of selection bias or confounding bias, and not an observation of a real phenomenon (11).

Thus, the relationship of BMI with short- and long-term outcomes after cardiac surgery remains controversial, and the dose-response relationship between BMI and mortality in patients receiving cardiac surgery is unclear. Moreover, the influences of age, concomitant disease, and types of surgery on the prognostic role of BMI has yet to be determined. To address these issues in depth, we used detailed clinical data obtained from the Multiparameter Intelligent Monitoring in Intensive Care (MIMIC-III) database (12) to investigate the relationship of BMI with in-hospital and 1-year outcomes after cardiac surgery. We present the following article in accordance with the STROBE reporting checklist (available at http://dx.doi.org/10.21037/jtd-20-2824).

Methods

Data source

Study data was extracted from the Multiparameter Intelligent Monitoring in Intensive Care III (MIMIC-III) database version 1.4 (12), which is an open-access database comprising the clinical data of over 40 thousand patients admitted to ICUs at the Beth Israel Deaconess Medical Center (Boston, MA, USA) from 2001 to 2012. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013).

Study population

All patients receiving open-heart surgery under extracorporeal circulation (ICD-9 code: 3961) were initially screened. Patients older than 18 years old and with weight and height records were included in the study. Patients were then divided into four groups according to the World Health Organization (WHO) BMI classifications: underweight (BMI <18.5 kg/m2), normal weight (BMI 18.5–25 kg/m2), overweight (BMI 25–30 kg/m2), and obese (BMI ≥30 kg/m2).

Data extraction

Data extraction was executed with structure query language (SQL) in PostgreSQL (v12.2; PostgreSQL Global Development Group). The following clinical variables were extracted: age, sex, weight, height, ethnicity, medical history [hypertension, diabetes, alcohol abuse, smoker, chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), obstructive sleep apnea (OSA), peripheral vascular disease], admission type (elective or emergency/urgent), type of cardiovascular surgery [valve surgery only, coronary artery bypass grafting (CABG) only, CABG + valve surgery, aortic surgery], vital signs within 24 hours after ICU admission [heart rate, systolic blood pressure, diastolic blood pressure, respiratory rate, oxygen saturation (SpO2), and blood glucose), laboratory tests within 24 hours after ICU admission (serum creatinine, white blood cell count (WBC), hemoglobin, platelet, partial thromboplastin time (PT), and activated partial thromboplastin time (APTT)], and the Simplified Acute Physiology Score II (SAPS-II) after ICU admission. When variables were measured more than once, the average of the highest and lowest values was taken.

Outcomes

The primary outcomes were the in-hospital and 1-year mortality. The secondary outcomes included ventilation duration, the time to weaning from vasopressors, length of ICU stays, length of hospital stays, and postoperative continuous renal replacement therapy (CRRT).

Statistical analysis

Continuous variables were checked for normality, which showed that all the continuous variables in this study were non-normally distributed. Thus, these non-normally distributed variables were reported as medians with interquartile ranges (IQRs), and compared by the Kruskal-Wallis test. Categorical variables are presented as numbers and proportions, and were compared using the Pearson’s chi-square or Fisher’s exact test. Multivariate Cox proportional hazard analysis was used to analyze factors related to 1-year mortality with hazard ratios (HRs) and 95% confidence interval (CI). Multivariate logistic regression analysis was used to identify factors related to in-hospital mortality with odds ratios (ORs) and 95% CI. Kaplan-Meier survival curves among the four BMI categories were constructed and compared using the log-rank test. BMI was also analyzed as a continuous variable. Restricted cubic splines were used to explore the nonlinear association between BMI and 1-year mortality. An optimal BMI cut point was determined to be 30 kg/m2 and was used as a knot for linear splines. The patient population was then divided into two subgroups (BMI <30 kg/m2 and BMI ≥30 kg/m2) according to the BMI cut point, and the adjusted HRs with 95% CIs associated with an increase in BMI by 1 kg/m2 in these two subgroups are reported respectively. Subgroup analyses were performed based on age, hypertension and types of surgery to determine their confounding influences. A case-control matched analysis was also performed to investigate the confounding influences of age and sex on the study results. Overweight or obese patients were matched 1:1 with normal/underweight patients according to age (±2 years) and sex. Kaplan-Meier survival curves and subgroup analysis were analyzed again in the matched cohorts. All statistical analyses were processed using SPSS 25.0 software (SPSS Inc., Chicago, IL, USA) and R programming language (version 4.0.0). All P values of <0.05 were considered statistically significant.

Results

Patient characteristics

The MIMIC-III database contains the data of 6,838 patients who receive open-heart surgery under extracorporeal circulation, 6,473 of whom met the inclusion criteria for this study ().

Figure 1

Flowchart of study cohort selection. MIMIC-III, Multiparameter Intelligent Monitoring in Intensive Care.

The proportions of patients by BMI category were as follows: underweight (BMI <18.5 kg/m2), 1.2% (n=78); normal weight (BMI 18.5–25 kg/m2), 26.4% (n=1,708); overweight (BMI 25–30 kg/m2), 38.5% (n=2,495); and obese (BMI ≥30 kg/m2), 33.9% (n=2,192). The baseline characteristics of patients are seen in . Patients with overweight (median age, 68 years) or obesity (median age, 65 years) were younger than normal weight patients (median age, 70). The proportion of male was higher in the overweight group (74.2%) compared with the normal weight group (63.9%), but was lower in the underweight group (34.6%). Meanwhile, the proportion of Asian patients in the overweight group (1.4%) and obese group (0.5%) was lower compared to the normal weight group (3.6%). Overweight and obese patients had a higher prevalence of hypertension (71.0% and 75.0% vs. 62.6%) and diabetes (28.3% and 44.1% vs. 22.7%) than normal weight patients. The prevalence of COPD was lowest in the overweight group (12.2%). Obese patients had the highest proportion of OSA (7.9%), and the lowest proportion of peripheral vascular disease (16.1%). The proportions of valve surgery in the overweight group (19.6%) and obese group (18.1%) were lower compared to the normal weight group (23.8%), while the proportions of CABG in the overweight group (55.2%) and obese group (59.7%) were higher compared to the normal weight group (46.7%). Overweight and obese patients had higher diastolic blood pressure, respiratory rate, blood glucose, serum creatinine, hemoglobin, PT, and lower SpO2, and APTT compared with normal weight patients (P<0.001). Obese patients had a higher heart rate (P=0.002), WBC count (P<0.001), platelet count (P<0.001), and lower SAPS II score (P=0.013) compared with normal weight patients.

Table 1

Baseline characteristics of 6,473 study patients by BMI category

Variables	Overall	Underweight	Normal weight	Overweight	Obese	P value	Missing
Number of patients, n (%)	6,473	78 (1.2)	1,708 (26.4)	2,495 (38.5)	2,192 (33.9)
BMI (kg/m2)	27.8 (24.7–31.6)	17.6 (16.9–18.1)^	23.1 (21.8–24.2)	27.4 (26.2–28.6)^	33.7 (31.5–37.2)^	<0.001*	0
Age (years)	67 (59–76)	71 (57–79)	70 (60–78)	68 (59–76)^	65 (57–73)^	<0.001*	0
Male, n (%)	4,455 (68.8)	27 (34.6)^	1,092 (63.9)	1,851 (74.2)^	1,485 (67.7)	<0.001*	0
Race, n (%)						<0.001*	0
White	4,614 (71.3)	49 (62.8)	1,217 (71.3)	1,771 (71.0)	1,577 (71.9)
Black	207 (3.2)	3 (3.8)	50 (2.9)	72 (2.9)	82 (3.7)
Asian	111 (1.7)	4 (5.1)	61 (3.6)	36 (1.4)^	10 (0.5)^
Hispanic or Latino	159 (2.5)	2 (2.6)	40 (2.3)	67 (2.7)	50 (2.3)
Other	1,382 (21.4)	20 (25.6)	340 (19.9)	549 (22.0)	473 (21.6)
Medical histories, n (%)
Hypertension	4,527 (71.3)	42 (53.8)	1,070 (62.6)	1,772 (71.0)^	1,643 (75.0)^	<0.001*	0
Diabetes	2,072 (32.0)	12 (15.4)	388 (22.7)	705 (28.3)^	967 (44.1)^	<0.001*	0
Alcohol abuse	151 (2.3)	1 (1.2)	35 (2.0)	68 (2.7)	47 (2.1)	0.39	0
Smoker	1,056 (16.3)	12 (15.4)	264 (15.5)	416 (16.7)	364 (16.6)	0.719	0
CKD	398 (6.1)	1 (1.3)	100 (5.9)	146 (5.9)	151 (6.9)	0.116	0
COPD	953 (14.7)	18 (23.1)	272 (15.9)	305 (12.2)^	358 (16.3)	<0.001*	0
OSA	267 (4.1)	0 (0)	28 (1.6)	65 (2.6)	174 (7.9)^	<0.001*	0
PVD	1,162 (18.0)	16 (20.5)	342 (20.0)	450 (18.0)	354 (16.1)^	0.017*	0
Admission type, n (%)
Elective	3,001 (46.4)	40 (51.3)	792 (46.4)	1,152 (46.2)	1,017 (46.4)	0.85	0
Emergency/urgent	3,472 (53.6)	38 (48.7)	916 (53.6)	1,343 (53.8)	1,175 (53.6)	0.85	0
Type of operation, n (%)						<0.001*	0
Valve only	1,320 (20.4)	28 (35.9)	406 (23.8)	489 (19.6)^	397 (18.1)^
CABG only	3,513 (54.3)	28 (35.9)	798 (46.7)	1,378 (55.2)^	1,309 (59.7)^
CABG + Valve	898 (13.9)	12 (15.4)	272 (15.9)	336 (13.5)	278 (12.7)^
Aortic surgery	485 (7.5)	5 (6.4)	137 (8.0)	212 (8.5)	131 (6.0)
Other	257 (4.0)	5 (6.4)	95 (5.6)	80 (3.2)^	77 (3.5)^
Vital signs within 24 h after ICU admission
Heart rate (bpm)	84 (79–90)	85 (80–92)	84 (78–90)	84 (79–90)	85 (79–91)^	0.002*	54
SBP (mmHg)	111 (106–118)	112 (106–121)	111 (105–118)	111 (106–118)	112 (107–118)	0.292	57
DBP (mmHg)	57 (53–61)	57 (53–62)	56 (52–60)	56 (53–61)^	57 (53–61)^	<0.001*	57
Respiratory rate (bpm)	17 (15–19)	17 (15–19)	16 (15–18)	17 (15–18)^	17 (16–19)^	<0.001*	53
SpO2 (%)	98 (97–99)	99 (98–99)	99 (98–99)	98 (97–99)^	98 (97–99)^	<0.001*	54
Blood glucose (mg/dL)	127 (118–139)	119 (108–130)	123 (115–135)	126 (118–137)^	130 (121–144)^	<0.001*	47
Laboratory tests within 24h after ICU admission
sCr (mg/dL)	0.9 (0.7–1.1)	0.7 (0.6–1.0)^	0.8 (0.7–1.0)	0.9 (0.7–1.1)^	0.9 (0.8–1.1)^	<0.001*	30
WBC (109/L)	12.1 (9.7–15.1)	10.6 (8.5–14.3)	11.5 (9.3–14.6)	11.9 (9.6–14.8)	12.7 (10.2–15.7)^	<0.001*	129
Hemoglobin (g/dL)	10.4 (9.5–11.5)	9.7 (9.0–10.2)^	10.1 (9.3–11.0)	10.5 (9.5–11.5)^	10.6 (9.6–11.7)^	<0.001*	16
Platelet (109/L)	165 (135–204)	146 (118–212)	158 (129–196)	161 (133–200)	173 (143–214)^	<0.001*	76
PT (s)	14.8 (14.0–15.8)	15.2 (14.2–16.3)	15.0 (14.2–15.9)	14.8 (14.0–15.8)^	14.7 (13.9–15.6)^	<0.001*	267
APTT (s)	35.6 (30.9–43.6)	39.7 (33.9–51.9)	38.3 (33.3–47.3)	35.8 (31.1–43.7)^	33.2 (29.5–39.5)^	<0.001*	262
SAPS II score after ICU admission	33 (27–41)	31 (25–39)	34 (27–42)	33 (27–40)	33 (26–41)^	0.013*	0

BMI, body mass index; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; OSA, obstructive sleep apnea; PVD, peripheral vascular disease; CABG, coronary artery bypass grafting; SBP, systolic blood pressure; DBP, diastolic blood pressure; sCr, serum creatinine; WBC, white blood cell count; SAPS-II, Simplified Acute Physiology Score II. Data are represented as median (interquartile range) or n(%). *, indicate statistical significance. ^, significant difference compared with normal weight category.

Study outcomes

Comparisons of the primary and secondary clinical outcomes among the four BMI categories are shown in . Ventilation duration (median time, 6.0 vs. 6.8 hours, P=0.002) and length of hospital stay (median time, 7.0 vs. 8.0 days, P<0.001) were shorter in the overweight group compared to the normal weight group. Length of ICU stay was shorter in the overweight group compared to the underweight group (median time, 2.2 vs. 3.0 days, P=0.005). The 1-year mortality rates were lower in the overweight (5.3%) and obese (5.9%) group compared with the normal weight group (9.0%).

Table 2

Univariate analysis of clinical outcomes in 6,473 patients by BMI category

Variables	Overall (n=6,473)	Underweight (n=78)	Normal weight (n=1,708)	Overweight (n=2,495)	Obese (n=2,192)	P value
Ventilation duration (h)	6.3 (3.6–17.0)	8.4 (4.2–19.1)	6.8 (3.7–17.1)	6.0 (3.5–16.0)^	6.3 (3.8–18.0)	0.002*
Time to weaning from vasopressors (h)	11.5 (1.2–24.5)	11.8 (1.7–22.8)	12.3 (1.5–29.8)	11.3 (1.0–29.1)	11.0 (1.0–29.8)	0.48
Length of ICU stays (d)	2.2 (1.2–4.1)	3.0 (1.4–6.4)	2.3 (1.3–4.2)	2.2 (1.2–4.0)#	2.2 (1.2–4.2)	0.005*
Length of hospital stays (d)	7.0 (5.0–11.0)	9.0 (6.0–14.0)	8.0 (5.0–12.0)	7.0 (5.0–11.0)^#	8.0 (5.0–11.0)#	<0.001*
CRRT, n (%)	123 (1.9)	0 (0)	38 (2.2)	34 (1.4)	51 (2.3)	0.017*
Mortality, n (%)
30-day	135 (2.1)	0 (0)	34 (2.0)	45 (1.8)	56 (2.6)	0.086
90-day	245 (3.8)	5 (6.4)	78 (4.6)	77 (3.1)	85 (3.9)	0.057
180-day	331 (5.1)	6 (7.7)	118 (6.9)	103 (4.1)^	104 (4.7)^	0.001*
1-year	422 (6.5)	6 (7.7)	154 (9.0)	132 (5.3)^	130 (5.9)^	<0.001*
In-hospital	129 (2.0)	0 (0)	37 (2.2)	43 (1.7)	49 (2.2)	0.172

CRRT, continuous renal replacement therapy. Data are represented as median (interquartile range) or n (%). *, indicate statistical significance. ^, significant difference compared with normal weight category; #, significant difference compared with underweight category.

The Kaplan-Meier survival curve of 1-year mortality is shown in , and suggests the notable 1-year survival advantage in the overweight and obese group compared with their normal weight counterparts (log-rank test P<0.001).

Figure 2

Kaplan-Meier curves of 1-year mortality by BMI category.

Multivariate Cox proportional hazard analysis showed that, overweight patients had a lower 1-year mortality compared to those with normal weight (HR=0.660, 95% CI: 0.516–0.843, P=0.001, ). In addition, age, hypertension, smoking, COPD, peripheral vascular disease, type of admission, type of operation, SpO2, blood glucose, serum creatinine, WBC, hemoglobin, PT, APTT and SAPS II score were also independently linked to 1-year mortality with a P<0.05 (). Multivariate logistic regression analysis showed that BMI category was not independently associated with in-hospital mortality (P=0.073, ). Age, hypertension, smoker, alcohol abuse, systolic blood pressure, SpO2, blood glucose, serum creatinine, APTT and SAPS II score were independently associated with in-hospital mortality with a P<0.05 ().

Table 3

Multivariate logistic regression analysis for in-hospital mortality and multivariate Cox proportional hazard analysis for 1-year mortality

Variables	In-hospital mortality				1-year mortality
	OR	95% CI	P value		HR	95% CI	P value
BMI category			0.073				0.009*
Underweight vs. normal	Not estimable		0.997		0.633	0.256–1.566	0.323
Overweight vs. normal	0.856	0.502–1.460	0.568		0.66	0.516–0.843	0.001*
Obese vs. normal	1.645	0.961–2.815	0.069		0.842	0.647–1.096	0.201
Age (years)	1.026	1.003–1.050	0.024*		1.035	1.023–1.047	<0.001*
Male	0.713	0.450–1.130	0.15		0.977	0.780–1.224	0.841
Race (ref. White)			0.74				0.426
Black	0.911	0.295–2.807	0.871		1.208	0.713–2.047	0.483
Asian	2.531	0.542–11.817	0.238		1.343	0.603–2.994	0.471
Hispanic or Latino	1.666	0.381–7.279	0.498		0.47	0.149–1.479	0.197
Other	1.124	0.677–1.867	0.652		1.151	0.899–1.473	0.265
Hypertension	0.476	0.304–0.745	0.001*		0.626	0.502–0.781	<0.001*
Diabetes	0.932	0.573–1.517	0.778		1.161	0.918–1.469	0.213
Alcohol abuse	3.285	1.159–9.308	0.025*		1.364	0.696–2.674	0.366
Smoker	0.269	0.110–0.655	0.004*		0.719	0.521–0.992	0.045*
CKD	1.47	0.758–2.849	0.254		1.33	0.957–1.849	0.089
COPD	1.255	0.727–2.166	0.414		1.594	1.244–2.042	<0.001*
OSA	1.189	0.445–3.176	0.73		0.899	0.519–1.556	0.703
PVD	1.655	0.968–2.830	0.065		1.402	1.079–1.821	0.011*
Elective admission	0.808	0.490–1.332	0.403		0.687	0.537–0.880	0.003*
Type of operation (ref. Valve)			0.116				0.001*
CABG	0.957	0.501–1.830	0.895		0.793	0.588–1.068	0.126
CABG + Valve	1.222	0.610–2.447	0.571		1.016	0.738–1.398	0.924
Aortic surgery	2.342	0.999–5.490	0.05		1.39	0.903–2.140	0.135
Other	2.313	0.838–6.386	0.106		1.994	1.203–3.307	0.007*
Heart rate (bpm)	0.99	0.971–1.010	0.331		0.999	0.990–1.007	0.919
SBP (mmHg)	0.977	0.955–1.000	0.046*		0.996	0.984–1.007	0.456
DBP (mmHg)	0.986	0.956–1.017	0.387		1.004	0.989–1.020	0.576
Respiratory rate (bpm)	1.061	0.995–1.130	0.07*		1.033	0.999–1.069	0.057
SpO2 (%)	0.854	0.766–0.951	0.004*		0.925	0.887–0.965	<0.001*
Blood glucose (mg/dL)	1.014	1.007–1.020	<0.001*		1.008	1.005–1.012	<0.001*
sCr (mg/dL)	1.481	1.312–1.673	<0.001*		1.291	1.217–1.369	<0.001*
WBC (109/L)	1.022	0.986–1.059	0.239		1.02	1.004–1.036	0.014*
Hemoglobin (g/dL)	0.951	0.804–1.123	0.551		0.862	0.792–0.939	0.001*
Platelet (109/L)	1.001	0.998–1.004	0.522		1.001	0.999–1.002	0.289
PT (s)	1.006	0.956–1.058	0.829		1.028	1.005–1.051	0.016*
APTT (s)	1.036	1.025–1.046	<0.001*		1.021	1.015–1.026	<0.001*
SAPS II score after ICU admission	1.033	1.015–1.051	<0.001*		1.017	1.008–1.026	<0.001*

BMI, body mass index; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; OSA, obstructive sleep apnea; PVD, peripheral vascular disease; CABG, coronary artery bypass grafting; SBP, systolic blood pressure; DBP, diastolic blood pressure; sCr, serum creatinine; WBC, white blood cell count; SAPS-II, Simplified Acute Physiology Score II. *, indicate statistical significance.

BMI was also analyzed as a continuous variable. The BMI cutoff of 30 kg/m2, was determined based on the shape of the restricted cubic splines (). Multivariate Cox proportional hazard analysis showed that, in the BMI <30 kg/m2 subgroup, each 1 kg/m2 of BMI increase was independently associated with a significant decrease in the 1-year mortality risk (HR =0.936, 95% CI: 0.899–0.975, P=0.002, ), while this association was not present in the BMI ≥30 kg/m2 subgroup (HR =1.032, 95% CI: 0.998–1.067, P=0.064, ).

Figure 3

Association of BMI and 1-year mortality (using restricted cubic splines with 3 knots). HR, hazard ratio.

Table 4

Multivariate Cox proportional hazard analysis for 1-year mortality in BMI subgroups (BMI analyzed as a continuous variable)

Variables	BMI <30 kg/m2 (n=4,281)				BMI ≥30 kg/m2 (n=2,192)
	HR	95% CI	P value		HR	95% CI	P value
BMI (kg/m2)	0.936	0.899–0.975	0.002*		1.032	0.998–1.067	0.064
Age (years)	1.03	1.016–1.044	<0.001*		1.05	1.026–1.074	<0.001*
Male	0.993	0.759–1.301	0.962		0.915	0.589–1.422	0.692
Race (ref. White)			0.598				0.319
Black	1.386	0.738–2.602	0.31		1.152	0.445–2.985	0.77
Asian	1.04	0.402–2.687	0.936		4.528	1.034–19.836	0.045
Hispanic or Latino	0.435	0.107–1.771	0.245		0.603	0.081–4.458	0.62
Other	1.092	0.811–1.472	0.562		1.186	0.752–1.871	0.463
Hypertension	0.65	0.499–0.847	0.001*		0.558	0.362–0.859	0.008*
Diabetes	1.397	1.046–1.865	0.023*		0.841	0.560–1.264	0.406
Alcohol abuse	1.561	0.725–3.361	0.255		0.851	0.202–3.576	0.825
Smoker	0.775	0.527–1.141	0.196		0.677	0.372–1.232	0.202
CKD	1.228	0.813–1.855	0.328		1.696	0.967–2.976	0.065
COPD	1.444	1.060–1.966	0.02*		1.727	1.112–2.683	0.015*
OSA	0.381	0.094–1.545	0.177		1.387	0.730–2.637	0.318
PVD	1.458	1.069–1.989	0.017*		1.128	0.662–1.923	0.657
Elective admission	0.603	0.445–0.818	0.001*		0.899	0.578–1.397	0.635
Type of operation (ref. Valve)			0.001*				0.297
CABG	0.733	0.511–1.050	0.091		0.961	0.545–1.694	0.89
CABG + Valve	1.108	0.757–1.620	0.598		0.92	0.497–1.705	0.792
Aortic surgery	1.323	0.798–2.194	0.279		2.209	0.927–5.265	0.074
Other	2.298	1.274–4.144	0.006*		1.581	0.562–4.448	0.385
Heart rate (bpm)	0.992	0.980–1.004	0.19		1.021	1.002–1.040	0.033*
SBP (mmHg)	1.002	0.989–1.015	0.737		0.982	0.960–1.004	0.106
DBP (mmHg)	1.001	0.982–1.020	0.933		1.009	0.980–1.038	0.559
Respiratory rate (bpm)	1.029	0.987–1.073	0.182		1.036	0.977–1.100	0.239
SpO2 (%)	0.91	0.859–0.965	0.001*		0.986	0.917–1.060	0.702
Blood glucose (mg/dL)	1.008	1.004–1.012	<0.001*		1.012	1.005–1.019	0.001*
sCr (mg/dL)	1.26	1.174–1.352	<0.001*		1.535	1.350–1.745	<0.001*
WBC (109/L)	1.022	1.006–1.037	0.006*		1.007	0.967–1.048	0.748
Hemoglobin (g/dL)	0.858	0.774–0.951	0.003*		0.908	0.774–1.065	0.236
Platelet (109/L)	1	0.999–1.002	0.57		1	0.998–1.003	0.724
PT (s)	1.027	0.998–1.058	0.071		1.046	1.008–1.085	0.018*
APTT (s)	1.02	1.014–1.026	<0.001*		1.022	1.011–1.033	<0.001*
SAPS II score after ICU admission	1.019	1.008–1.029	<0.001*		1.01	0.993–1.028	0.248

BMI, body mass index; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; OSA, obstructive sleep apnea; PVD, peripheral vascular disease; CABG, coronary artery bypass grafting; SBP, systolic blood pressure; DBP, diastolic blood pressure; sCr, serum creatinine; WBC, white blood cell count; SAPS-II, Simplified Acute Physiology Score II. *, indicate statistical significance.

Subgroup analysis

Subgroup analysis was performed according to age, hypertension and types of surgery (). In the age 60–80 and >80 years subgroups, overweight was significantly associated with a lower 1-year mortality compared with normal/underweight patients (HR =0.651, 95% CI: 0.483–0.879 and HR =0.465, 95% CI: 0.294–0.737, respectively), while in patients aged≤60 years, the relationship was not significant (P=0.480). In patients with hypertension, overweight or obese was significantly associated with a lower 1-year mortality compared with normal/underweight patients (HR =0.504, 95% CI: 0.375–0.677 and HR =0.566, 95% CI: 0.423–0.759, respectively), while in non-hypertensive patients, this relationship was not significant (P=0.391). Of the surgery type subgroups (valve only, CABG only, CABG + valve and aortic), only in the CABG subgroup was overweight or obese significantly associated with a lower 1-year mortality compared with normal/underweight patients (HR =0.483, 95% CI: 0.333–0.703 and HR =0.658, 95% CI: 0.463–0.934, respectively).

Figure 4

Hazard ratios of 1-year mortality risk on the stratification of age levels, hypertension and types of operation. Patients with BMI <25 kg/m2 (underweight and normal weight) acts as the reference group.

Case-control matched analysis

Overweight and obese patients were separately matched 1:1 with normal/underweight patients based on age (±2 years) and sex. Kaplan-Meier survival curves of 1-year mortality in matched cohorts are shown in , and indicated that 1-year survival is still higher in the overweight and obese groups compared with the normal/underweight group (log-rank test P<0.001). Subgroup analysis was also performed in the matched cohorts (), and suggested that age and sex differences did not affect the survival advantage of the overweight and obese groups in the hypertension and isolated CABG cohorts.

Figure 5

Kaplan-Meier curves of 1-year mortality in age and sex matched cohorts. Overweight (A) and obese (B) patients were separately matched 1:1 with normal/underweight patients based on age (±2 years) and sex.

Table 5

Subgroup analysis in age and sex matched cohorts

Study cohort	Sample size	HR	95% CI	P value
Overweight vs. Normal/underweight matched
Overall	3,434	0.571	0.443–0.738	<0.001*
Hypertension	2,293	0.463	0.330–0.650	<0.001*
Isolated CABG	1,706	0.546	0.363–0.822	0.004*
Obese vs. Normal/underweight matched
Overall	3,096	0.586	0.454–0.755	<0.001*
Hypertension	2,115	0.485	0.350–0.670	<0.001*
Isolated CABG	1,631	0.549	0.368–0.817	0.003*

CABG, coronary artery bypass grafting. *, indicate statistical significance.

Discussion

The present study suggested that overweight patients undergoing cardiac surgery with extracorporeal circulation had better 1-year survival compared to their normal weight counterparts after adjusting for confounding factors. The optimal BMI for 1-year survival after cardiac surgery appeared to approximate the overweight/mild obesity level (BMI =30 kg/m2). This obesity paradox was limited to patients with advanced age (>60 years), hypertension, and those undergoing isolated CABG.

Studies of the relationship between BMI and cardiac surgery outcome in diverse patient populations and with different follow-up times have generated controversial results. A nationwide cohort study comprising 401,227 patients undergoing cardiac surgery observed a decreased in-hospital mortality in overweight and obese class I and II patients, and an increased in-hospital mortality in underweight patients (6). Another large cohort study including 96,058 elderly patients (≥60 years old) receiving isolated CABG showed that low (<18.5 kg/m2) and high (≥30 kg/m2) BMI were associated with higher risk of operative mortality (13). However, a recent study of 16,252 patients undergoing mitral valve surgery for degenerative disease failed to demonstrate an association between BMI and in-hospital outcome (8). Study results pertaining to long-term outcomes, are also inconsistent. One study comprising 78,762 patients receiving CABG or combined CABG/aortic valve replacement showed that overweight and obese patients had better 1- and 5-year survival rates (14), while others found no relationship between high BMI and an increased probability of long-term survival (9,15). The results of the present study agreed with previous reports that reported overweight to be associated with better long-term post-cardiac surgery survival compared to normal weight (16).

There may be several reasons explaining the obesity paradox seen in cardiac surgery. Obese patients are usually younger, while underweight patients are more likely to have frailty, cachexia, or severe chronic disease, which may lead to a confounding bias (11). Another hypothesis is that obese patients are admitted to cardiac surgery only if they are subjectively at lower risk, leading to a selection bias (15). In the present study, overweight remained an independent protective factor for 1-year survival after adjusting for confounding factors, which suggested that there may be potential mechanisms underlying the direct protective effect of a higher BMI. Some adipokines produced by adipose tissue had been proved to provide cardiovascular benefits, such as regeneration of damaged myocardium, reduction of afterload, inhibition of myocardium fibrosis, and promotion of angiogenesis (17).

The present study showed that the protective effect of overweight after cardiac surgery was confined to elderly patients (>60 years). Similar findings have been observed in patients with ST-segment elevation myocardial infarction (18), atrial fibrillation (19), and in survivors of sudden cardiac arrest (20). Many age-related changes including increases in visceral fatness, chronic inflammation, oxidative stress, decreased body height, muscle mass, energy expenditure, changes in neurohormonal, metabolism, and higher prevalence of frailty, undernutrition and chronic disease, might contribute to this phenomenon (21). Another interesting finding of our subgroup analysis was that overweight/obese served as a protective factor for post-cardiac surgery survival only in hypertensive patients. Previous studies have shown that in a population with hypertension and coronary artery disease, overweight and obese patients had decreased morbidity and mortality compared with normal weight patients (22). A remarkable disparity in regional sympathetic activity between normal weight hypertension and obesity-hypertension has also been reported. Cardiac sympathetic activity was increased in normal weight hypertensive patients, but was at a normal or low level in those who were obese (23). The theory that a more toxic form of sympathetic activation may be present in normal weight hypertension compared with obese-hypertension might explain the obesity paradox in hypertension. Our subgroup analysis also suggested that the association between BMI and 1-year survival was found only in isolated CABG patients, which was consistent with previous cohort studies and meta-analyses (16,24). However, a recent meta-analysis presented the opposite results, in which a decreased mortality was found in patients after valve surgery but not after CABG (7). Further studies are needed to determine the prognostic effect of BMI in different types of cardiac surgery.

The limitations of the present study are as follows: first, this is a retrospective single-center study, and it was difficult to exclude the influence of some potential confounding factors on the results. Secondly, due to the nature of the MIMIC database, some important information such as the New York Heart Association functional class, cardiac function parameters and operative details were not available. Moreover, the sample size of some subgroups was small, and might not have provided sufficient statistical power to draw credible conclusions.

Conclusions

In conclusion, the present retrospective cohort study showed that overweight was associated with better 1-year survival in patients after cardiac surgery when compared to normal weight. The protective effect of overweight on post-cardiac surgery survival was confined to elderly patients (>60 years).

The article’s supplementary files as